BerganKDV Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15
Closed 1066
2022
Q3
$0 Hold
15
﹤0.01% 996
2022
Q2
$1K Buy
15
+10
+200% +$535 ﹤0.01% 893
2022
Q1
$0 Hold
5
﹤0.01% 1024
2021
Q4
$0 Hold
5
﹤0.01% 1074
2021
Q3
$0 Sell
5
-6
-55% -$633 ﹤0.01% 1053
2021
Q2
$1K Buy
11
+1
+10% +$119 ﹤0.01% 901
2021
Q1
$1K Buy
10
+5
+100% +$684 ﹤0.01% 845
2020
Q4
$1K Hold
5
﹤0.01% 846
2020
Q3
$1K Hold
5
﹤0.01% 789
2020
Q2
$0 Sell
5
-8
-62% -$639 ﹤0.01% 994
2020
Q1
$1K Hold
13
﹤0.01% 815
2019
Q4
$1K Buy
+13
New +$1.14K ﹤0.01% 840

Other funds holding EXAS

BerganKDV Wealth Management's EXAS Position: Q4 2022 in Review

BerganKDV Wealth Management sold out of Exact Sciences (EXAS) in Q4 2022, closing a stake of 15 shares.

BerganKDV Wealth Management first reported a position in EXAS in Q4 2019 and held it in 12 quarters. The position peaked at $1K in Q2 2022. 551 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

  • BerganKDV Wealth Management reported no remaining Exact Sciences position as of Q4 2022 after selling out during the quarter.
  • BerganKDV Wealth Management sold 15 Exact Sciences shares in Q4 2022.
  • BerganKDV Wealth Management first reported a position in Exact Sciences in Q4 2019 and held it in 12 quarters.
  • BerganKDV Wealth Management's Exact Sciences position peaked at $1K in Q2 2022.
  • 551 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on BerganKDV Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.